Companion diagnostics-a tool to improve pharmacotherapy.
about
ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice.Composite iron oxide-Prussian blue nanoparticles for magnetically guided T1-weighted magnetic resonance imaging and photothermal therapy of tumors.PD-L1 immunohistochemistry for non-small cell lung carcinoma: which strategy should be adopted?Clinical and Regulatory Aspects of Companion Diagnostic Development in Oncology.Harnessing the Digital Exhaust: Incorporating wellness into the pharma model
P2860
Companion diagnostics-a tool to improve pharmacotherapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Companion diagnostics-a tool to improve pharmacotherapy.
@en
Companion diagnostics-a tool to improve pharmacotherapy.
@nl
type
label
Companion diagnostics-a tool to improve pharmacotherapy.
@en
Companion diagnostics-a tool to improve pharmacotherapy.
@nl
prefLabel
Companion diagnostics-a tool to improve pharmacotherapy.
@en
Companion diagnostics-a tool to improve pharmacotherapy.
@nl
P2860
P356
P1476
Companion diagnostics-a tool to improve pharmacotherapy.
@en
P2093
Jan Trøst Jørgensen
Maria Hersom
P2860
P356
10.21037/ATM.2016.12.26
P577
2016-12-01T00:00:00Z